Event Listings
 
Active Pharmaceutical Ingredients Market showcasing a CAGR of 6.4% during the period of 2017 to 2023

A recent business and commerce study by Transparency Market Research (TMR) has detected that the value chain of the active pharmaceutical ingredient (API) market is supported by players who specialize in specific technologies, and as a result are maintaining an edge on the back of their expertise in production. Companies such as BASF, DuPont, Dow Chemicals, and Bayer are some of the leading chemical manufacturers. API manufacturing is gradually being concentrated in the Asia-Pacific countries, particularly India, with companies such as Sun Pharma, Teva, Takeda, Orchid Pharma, and Cipla being prominent players. Demand for specialized APIs for biological drugs is increasing gradually too, which makes for a segment that is dominated by players such as PolyPeptide Group, Bachem Group, Otsuka Chemicals, and Lonza.

Read Report Overview: https://www.transparencymarketresearch.com/active-pharmaceutical-ingredients.html

Major challenge for specialized active pharmaceutical ingredient manufacturers is the optimization of economies of scale through application of sophisticated technologies and enter into long-term contracts with western drug manufacturers. Through time, API manufacturers have forward integrated to manufacture their own drugs in order to expand profit margins and better explore the pharmaceutical landscape

Global API market to be worth US$219,601.9 by 2023

The TMR report has estimated that the global market for active pharmaceutical ingredients will be worth US$219,601.9 by the end of 2023, mounting from its evaluated worth of US$151,591.7 as of 2017, showcasing a CAGR of 6.4% during the period of 2017 to 2023. The report has identified captive manufacturing a stronger segment than contract manufacturing in the API market, whereas synthetic chemical API are in greater demand than biological APIs. Additionally, branded prescription drugs are the leading drug type segment. The report has also gauged the potential of demand that can be expected during the aforementioned forecast period from the therapeutic areas of cardiovascular, NSAIDs, metabolic, neurological, oncology, musculoskeletal, and other usages as well as in the regions of North America, Asia Pacific, Europe, and the Rest of the World (RoW). Availability of technically efficient manpower and cost effectiveness is poised to turn India and thereby Asia Pacific a highly lucrative region in the near future.

Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1690

Prevalence of Chronic Diseases Driving Demand

The healthcare industry has been on an upward curve in the past couple of decades as a result of economic growth of a number of developing countries and robust reimbursement mandates in developed nations. As a result, the pharmaceutical manufacturers are busier than ever, catering to expanding demand generated by the prevalence of chronic diseases. In addition to that, lifestyle inflicted diseases are on the rise too, apart from increasing percentage of geriatrics in the world’s population. The analyst of the report also has highlighted the strengthening presence of Indian drug manufacturers in the API market. Indian API manufacturers have been investing to comply with the U.S. FDA regulations, and to win contracts from the U.S. based companies, and have been filing the drug master file (DMF) applications. All these factors are expected to reflect positively on the global active pharmaceutical ingredients market in the near future.

Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1690

On the other hand, compliance with regulatory is the primary hurdle challenging the API market at every step of the way. The exporters of active pharmaceutical ingredients now have to abide by the good manufacturing practice (GMP) in the European region, while FDA is regulating quality assurance in the U.S. and other regions. According to the analyst, while these regulations are helping to improve and maintain quality of drugs, they are also restricting the API manufacturing market especially in developing economies from Asia-Pacific.

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/


Event Date: 28 May 2018 Contact Person: sneha
Venue: Email:
Country: India Tel:

Submitted by Sandy Researcher, Transparency Market Research on Monday, 28 May 2018 at 3:39 PM
Category: Health Care & Medical
 
Related News

Anatomic Pathology Testing market Will Generate New Growth Opportunities By 2025
Wednesday, 20 Mar 2019

Morgellons Disease Market Analysis and Research Report by Experts 2025
Wednesday, 20 Mar 2019

Allergic Asthma Treatment Market Analysis and Research Report by Experts 2025
Wednesday, 20 Mar 2019

Arrhythmia Market Analysis and Research Report by Experts 2017 - 2025
Wednesday, 20 Mar 2019

High Performance Liquid Chromatography Market Analysis and Research Report by Experts 2025
Wednesday, 20 Mar 2019

Related Events

World Pharma Pricing and Market Access Congress 2019
Tuesday, 19 Mar 2019

Innate Killer Summit 2019
Tuesday, 19 Mar 2019

Middle East Pharmaceutical Cold Chain Conference
Tuesday, 19 Mar 2019

ICO-IO Combinations Summit 2019
Tuesday, 19 Mar 2019

Clinical Reviews 2019: 30th Annual Family Med And Internal Med Update
Wednesday, 20 Mar 2019

Upcoming Events

World Pharma Pricing and Market Access Congress 2019
Tuesday, 19 Mar 2019

Innate Killer Summit 2019
Tuesday, 19 Mar 2019

Credit Week 2019, London
Tuesday, 19 Mar 2019

Middle East Pharmaceutical Cold Chain Conference
Tuesday, 19 Mar 2019

ICO-IO Combinations Summit 2019
Tuesday, 19 Mar 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Wednesday, 20 March 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Latest Press Releases
  • Witness an Exciting Photography Expedition in North Sichuan with Absolute Panda
  • Europe Baby Drinks Market: Rising Number of Working Women to Drive Market Growth
  • Bridesmaid Dresses to Pair With Red Wedding Gown
  • Food Additives Market to Reach US$39.8 bn by 2021, Increasing Consumption to Aid in Rap-id Expansion
  • Asthma Therapeutics Market Is Expected To Reach USD 23.4 Bn By 2024: Credence Research

  • Latest Jobs
    Sorry, there are currently no entries posted here.